You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.

  1. An Integrated Pan Genome Resistome Platform for Nosocomial Pathogen Surveillance in Hospitals

    SBC: ICBiome            Topic: NIAID

    Nosocomial hospital infections are a significant public health concern as they severely harm patients disrupt normal operations and increase hospital costs To reduce these risks and allow for preemptive responses there is a critical need for routine surveillance of nosocomial pathogens within a hospital environment patients staff ventilation equipment With the decreasing costs of sequenci ...

    SBIR Phase I 2017 Department of Health and Human ServicesNational Institutes of Health
  2. Augmenting Endoscopic Instruments with Real-time 3D Imaging

    SBC: Xyken, LLC            Topic: NIA

    Project SummaryAging increases the risk of GI disorders such as CRCinflammatory bowel diseaseand appendicitisNIH statistic shows thattomillion people are affected by digestive diseasesIncreasing global geriatric population base is expected to further worsen this situation over the coming yearsAnnuallydiseases of the gastrointestinalGItract account for more thanmillion office visits and more thanmi ...

    SBIR Phase I 2017 Department of Health and Human ServicesNational Institutes of Health
  3. Promoting AdheRence via Objective Technology to Assess Cystic Fibrosis Treatment PROTRACT

    SBC: BARRON ASSOCIATES, INC.            Topic: NHLBI

    Significance The proposed research Promoting AdheRence via Objective Technology to Assess Cystic Fibrosis Treatment PROTRACT will develop a novel cost effective system that combines multiple sensing modalities to provide an accurate practical and affordable method for reliably assessing adherence to treatment of cystic fibrosis CF Problem to be Addressed CF is a life shortening disea ...

    SBIR Phase I 2017 Department of Health and Human ServicesNational Institutes of Health
  4. Web-Based Alcohol Misuse Prevention Intervention for the Elderly

    SBC: ISA ASSOCIATES INC            Topic: NIAAA

    DESCRIPTIONprovided by applicantRecent data indicate that a substantial proportion of adultsyears of age and older are engaging in unsafeat risk drinkingeither based on the amount of alcohol they drink or alcohol use combined with other comorbidities or medicationsSeveral brief interventions to address the problem of excessive drinking in the elderlydesigned mainly for in person deliverymost in pr ...

    SBIR Phase II 2017 Department of Health and Human ServicesNational Institutes of Health
  5. A New Approach to Vision Therapy Based on Naturalistic 3-D Computer Gaming

    SBC: BARRON ASSOCIATES, INC.            Topic: NEI

    Summary Abstract IntroductioniCare will provide e ectivehome based vision therapy through a motivating action based video game that inspires adherence in patients as young asyears oldThe proposed Phase IIB e ort supports development of the commercial systemcloud based tools for providers and patientsestablishment of e cacy and safetyand federal regulatory approvalProblem to be addressedConvergence ...

    SBIR Phase II 2017 Department of Health and Human ServicesNational Institutes of Health
  6. he 3D Platelet Bank: A Clinical-grade, Scalable, 3D Microbioreactor Bone Marrow Mimetic for Platelet Production

    SBC: KIYATEC, LLC            Topic: NIBIB

    Project Summary Abstract The transfusion of platelets is a major component of the treatment of cancer patients undergoing chemotherapy and or bone marrow transplantstrauma patientssepsisand battlefield injuriesHoweverdue to a complete reliance upon donors as the only current approved source of plateletsand the strictshort shelf life and storage conditions of donorderived plateletscurrent supplies ...

    SBIR Phase II 2017 Department of Health and Human ServicesNational Institutes of Health
  7. Identification and validation of targets for therapeutic intervention in rare diseases of intermediary metabolism

    SBC: HemoShear Therapeutics, LLC            Topic: 300

    Fast Track SBIRIdentification and validation of targets for therapeutic intervention in rare diseases of intermediary metabolism defectsABSTRACT There are very few reliable methods to study and understand the biology of liver rare diseases in the laboratory for the purpose of drug discovery and developmentwhich contributes to a dismal record for development of new treatmentsFirstgenetic mouse mode ...

    SBIR Phase II 2017 Department of Health and Human ServicesNational Institutes of Health
  8. Polo box PLK Inhibitors Target Tumors Resistant to ATP Competitive Compounds

    SBC: PPI PHARMACEUTICALS, LLC            Topic: NCI

    Polo like kinase PLK is a central player in regulating entry into and progression through mitosis Many studies have validated PLK as an anti tumor drug target and its inhibition is potently anti proliferative to cancer cells However recent data suggests that there are two major disadvantages of the conventional approach to blocking the kinase activity of PLK First both general kinome ...

    STTR Phase I 2017 Department of Health and Human ServicesNational Institutes of Health
  9. Development of Peptide Inhibitor of Complement to treat neonatal asphyxial brain damage

    SBC: Childrens Specialty Group PLLC            Topic: NIAID

    Abstract The hypothesis for the proposed project is that inhibition of the classical complement pathway with Peptide Inhibitor of complement C PIC will be neuroprotective in a rat model of neonatal hypoxic ischemic encephalopathy HIE HIE is an ischemia reperfusion injury of the brain that occurs around the time of birth with up to mortality and of survivors left with a significant ...

    SBIR Phase I 2017 Department of Health and Human ServicesNational Institutes of Health
  10. Reducing Cervical Cancer Health Disparities among African American Women An mHealth Approach to Improving Prevention and Treatment Outcomes

    SBC: ISA ASSOCIATES INC            Topic: NIMHD

    African American women in the United States continue to be disproportionately burdened by cervical cancer The incidence rate is higher in black women than white women Black women are also twice as likely to die from the disease The year survival rate is for black women It is for white women And yet it does not have to be this way A multifaceted preventive approach could potent ...

    SBIR Phase I 2017 Department of Health and Human ServicesNational Institutes of Health
US Flag An Official Website of the United States Government